# Glycemic Regulation as Endometriosis Adjunct Treatment

> **NCT06611501** · PHASE2 · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 14 (estimated)

## Conditions studied

- Pelvic Pain
- Endometriosis

## Interventions

- **DRUG:** Metformin Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06611501
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-22
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06611501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06611501, "Glycemic Regulation as Endometriosis Adjunct Treatment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06611501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*